BioCentury
ARTICLE | Clinical News

Clonicel clonidine regulatory update

October 5, 2009 7:00 AM UTC

Addrenex submitted an sNDA to FDA for Clonicel clonidine to treat attention-deficit hyperactivity disorder (ADHD). Clonicel is a modified-release formulation of clonidine, an adrenergic receptor alph...